Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;9(6):793-7.
doi: 10.2217/rme.14.57.

A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network

John W Petersen  1 , David E Winchester, Ki Park, Anita D Szady, Domenico G Della Rocca, Mustafa Ahmed, Hillary Tassin, Yanfei Qi, Carl J Pepine
Affiliations

A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network

John W Petersen et al. Regen Med. 2014.

Abstract

Stem/progenitor cell-based therapies offer novel treatment for many prevalent diseases. However, most physicians are not trained or introduced to cell therapy. We describe a model of a training program aimed at empowering physician-scientists with the knowledge and skills necessary for advancing the field of cardiovascular cell therapy. To date, five full-time scholars have completed this training program, obtained a full-time academic appointment in Cardiovascular Disease, and continue to actively contribute to the advancement of cell therapy applications. Another has returned to his parent institution to complete his PhD and several part-time scholars have continued in scholarly activities in other academic programs.

Keywords: cardiovascular; fellowship training; physician training; regenerative medicine; stem cell.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

References

    1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–e245. - PMC - PubMed

    1. Szady AD, Pepine CJ, Sharma SV, et al. A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials. Curr. Atheroscler. Rep. 2013;15:341. • Provides insights on the design of stem cell trials with emphasis on outcomes. Demonstrates our progress in cardiovascular cell therapy trial design.

    1. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. - PubMed

    1. Knoepfler PS. Call for fellowship programs in stem cell-based regenerative and cellular medicine: new stem cell training is essential for physicians. Regen. Med. 2013;8:223–225. •• Highlights the importance of academic fellowship training in the field of stem cell-based therapies and research.

    1. Traverse JH, Henry TD, Ellis SG, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011;306:2110–2119. • Demonstrates progress of the Cardiovascular Cell Therapy Research Network (CCTRN) in the field of cardiovascular cell therapy.

Publication types

LinkOut - more resources